Associate Professor, Department of Urology
The research projects in our laboratory are centered on the mechanisms of action of metformin, the most prescribed anti–type II diabetes medicine. We are particularly interested in its antineoplastic effects and its impact on bone metabolism in diabetes.
Using various animal and cell culture models and molecular and cellular techniques, we have revealed the role of metformin as an epigenetic regulator and metabolic rebalancer, restoring normal cellular function in cancer and diabetes.
Associate Professor, Department of Urology at NYU Grossman School of Medicine
University of Michigan, Laurie McCauley
Molecular oral microbiology. 2024 Apr; 39(2):80-90
Gut. 2023 Dec 07; 73(1):175-185
BMC musculoskeletal disorders. 2023 Jan 20; 24(1):48
European spine journal. 2023 Jan; 32(1):149-166
Cell. 2022 Sep 29; 185(20):3648-3651
Cell reports. 2022 Sep 20; 40(12):111389